384830-13-1 Usage
Uses
Given the general properties of piperidine compounds and the presence of functional groups in tert-butyl 3-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate, potential applications can be inferred in various industries:
Used in Pharmaceutical Industry:
Tert-butyl 3-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate is used as a pharmaceutical intermediate for the synthesis of various drugs. Its complex structure and functional groups make it a versatile building block in the development of new medications, potentially targeting a range of therapeutic areas.
Used in Chemical Research:
In the field of chemical research, tert-butyl 3-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate serves as a subject for studying the synthesis and reactivity of complex organic molecules. Its unique structure can provide insights into the behavior of piperidine compounds and their derivatives.
Used in Material Science:
tert-butyl 3-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate may also find applications in material science, where its specific properties, such as its ability to form complexes or its reactivity, could be harnessed to create new materials with unique characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 384830-13-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,4,8,3 and 0 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 384830-13:
(8*3)+(7*8)+(6*4)+(5*8)+(4*3)+(3*0)+(2*1)+(1*3)=161
161 % 10 = 1
So 384830-13-1 is a valid CAS Registry Number.
InChI:InChI=1/C14H25NO4/c1-5-18-12(16)9-11-7-6-8-15(10-11)13(17)19-14(2,3)4/h11H,5-10H2,1-4H3
384830-13-1Relevant articles and documents
TRIAZOLE-PYRIDINYL SUBSTITUTED AZACYCLOHEXYL ACETIC ACID COMPOUNDS AS LPA RECEPTOR ANTAGONISTS
-
Paragraph 0331, (2022/02/28)
This application relates to novel substituted azacyclohexyl acetic acid compounds, their manufacture, pharmaceutical compositions comprising them, and their use as medicaments for treating a disease associated with dysregulation of lysophosphatidic acid receptors (LPA).
SUBSTITUTED QUINOLONES III
-
Page/Page column 13, (2009/07/25)
The invention relates to substituted quinolones and to methods for their preparation as well as to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses.
Beta lactam compounds and their use as inhibitors of tryptase
-
Page column 257, (2010/11/29)
Compounds of the formulas: are disclosed. These compounds inhibit tryptase as well as other enzyme systems or are selective tryptase inhibitors and are useful as antiinflammatory agents particularly in the treatment of chronic asthma.